Tadalafil, a Phosphodiesterase-5 Inhibitor, Improves Erectile Dysfunction in Patients With Liver Cirrhosis.
Sign Up to like & getrecommendations! Published in 2019 at "Journal of clinical and experimental hepatology"
DOI: 10.1016/j.jceh.2018.07.007
Abstract: Background Erectile dysfunction(ED) is common in patients with chronic liver disease(CLD). Although it significantly worsens the quality of life, caregivers and researchers often neglect it. Aim Evaluating the prevalence of ED in patients with CLD,… read more here.
Keywords: erectile dysfunction; score; tadalafil phosphodiesterase; etiology ... See more keywords